PON2 and cancer: In this light, PON2 activity, interacting with coenzyme Q10 and lowering of O2− production, leads to the reduction of both cardiolipin peroxidation and cytochrome C release, thus significantly contributing to cancer cell resistance to apoptosis triggered by oxidative stress.